New eye drops offer hope for rare corneal condition
NCT ID NCT07422389
First seen Feb 20, 2026 · Last updated May 13, 2026 · Updated 10 times
Summary
This program provides access to BRM421 eye drops for adults with mild to moderate limbal stem cell deficiency (LSCD) who are not satisfied with standard treatments. Participants use the drops twice a day for at least 12 weeks and visit the clinic monthly for checkups. The goal is to manage the condition and improve eye health.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for LIMBAL STEM CELL DEFICIENCY (LSCD) are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Scheie Eye Institute
AVAILABLEPhiladelphia, Pennsylvania, 19104, United States
Contact
Conditions
Explore the condition pages connected to this study.